Amundi’s AbbVie ABBV Stock Holding History

Amundi’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.53B	Sell	10,039,289 -658,806	-6%	-$142M	0.61%	25
2026 Q1	$2.33B	Buy	10,698,095 +247,689	+2%	+$54.9M	0.63%	19
2025 Q4	$2.39B	Sell	10,450,406 -57,911	-0.6%	-$13.2M	0.65%	17
2025 Q3	$2.42B	Buy	10,508,317 +1,414,621	+16%	+$288M	0.78%	17
2025 Q2	$1.73B	Buy	9,093,696 +2,435,372	+37%	+$453M	0.6%	22
2025 Q1	$1.34B	Sell	6,658,324 -1,688,972	-20%	-$328M	0.49%	37
2024 Q4	$1.49B	Buy	8,347,296 +717,403	+9%	+$132M	0.52%	30
2024 Q3	$1.47B	Buy	7,629,893 +520,371	+7%	+$97.1M	0.54%	34
2024 Q2	$1.16B	Buy	7,109,522 +807,799	+13%	+$134M	0.45%	46
2024 Q1	$1.04B	Sell	6,301,723 -1,680,202	-21%	-$290M	0.45%	38
2023 Q4	$1.3B	Sell	7,981,925 -235,414	-3%	-$34.3M	0.58%	25
2023 Q3	$1.22B	Sell	8,217,339 -838,371	-9%	-$123M	0.6%	24
2023 Q2	$1.22B	Buy	9,055,710 +403,503	+5%	+$59.2M	0.62%	24
2023 Q1	$1.39B	Buy	8,652,207 +2,494,894	+41%	+$381M	0.75%	20
2022 Q4	$969M	Buy	6,157,313 +997,983	+19%	+$153M	0.53%	28
2022 Q3	$739M	Sell	5,159,330 -346,952	-6%	-$49.8M	0.44%	39
2022 Q2	$828M	Buy	5,506,282 +783,076	+17%	+$120M	0.66%	25
2022 Q1	$818M	Sell	4,723,206 -958,881	-17%	-$139M	0.55%	31
2021 Q4	$760M	Sell	5,682,087 -134,837	-2%	-$15.9M	0.48%	41
2021 Q3	$627M	Buy	5,816,924 +1,236,167	+27%	+$141M	0.44%	49
2021 Q2	$516M	Buy	+4,580,757	New	+$516M	0.36%	57

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Amundi's ABBV Position: Q2 2026 in Review

Amundi reduced its AbbVie (ABBV) stake by 6.2% in Q2 2026, selling an estimated $142M and leaving 10,039,289 shares worth $2.53B. The position accounts for 0.61% of the portfolio, ranked #25.

Amundi first reported a position in ABBV in Q2 2021 and has held it in 21 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Amundi held 10,039,289 shares of AbbVie worth $2.53B as of Q2 2026.
Amundi sold 658,806 AbbVie shares in Q2 2026, an estimated $142M.
AbbVie made up 0.61% of Amundi's portfolio in Q2 2026, its #25 holding.
Amundi first reported a position in AbbVie in Q2 2021 and has held it in 21 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.